
@ShahidNShah
As it prepares to go public, telehealth company Amwell priced its stock late Tuesday between $14 and $16 per share.
The company aims to sell 35 million shares of its Class A common stock, which would bring in gross proceeds of $490 million to $560 million, according to its updated S-1 filing with the Securities and Exchange Commission (SEC).
Amwell estimates the proceeds from the IPO will be approximately $488 million, or $538 million if the underwriters exercise their option to purchase additional shares of Class A common stock at $15 per share.
Continue reading at fiercehealthcare.com
During the height of the COVID-19 pandemic, as normal hospital workflows were disrupted, providers often struggled to get the critical patient information they needed. This was particularly true in …
Posted Sep 14, 2020data sharinghospitalpandemic
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2025 Netspective Foundation, Inc. All Rights Reserved.
Built on Feb 21, 2025 at 1:11pm